Medtronic Reaffirms Commitment to Shanghai as Global Innovation Hub Following Meeting with Mayor Gong Zheng

It is hoped that Medtronic will continue to deepen and improve its full industry chain layout in Shanghai, and place more high-quality resources, major projects, and functional sectors in Shanghai.

Shanghai Mayor Gong Zheng met today (March 25) with a delegation led by Geoff Martha, Chairman and CEO of Medtronic.

Gong Zheng said that Shanghai is currently focusing on the construction of the "five centers" as its main direction and important mission, accelerating the development into a socialist modern international metropolis with global influence. Biomedical industry is one of the three leading industries that Shanghai prioritizes for development. We will continue to enhance the innovation-driven capabilities of the biomedical industry, expand pilot programs in opening up the medical field, and accelerate the establishment of a globally influential biomedical innovation hub. We hope Medtronic will further deepen and refine its full industrial chain layout in Shanghai, allocate more high-quality resources, major projects, and functional sectors to Shanghai, and expand the scale of R&D, production, and training operations. Actively support local companies in innovative development and promote the localization of R&D and production of more medical technology products. Shanghai is continuously working to create a first-class business environment that is market-oriented, law-based, and internationalized. Companies are welcome to provide suggestions on optimizing Shanghai's business environment.

Jeff Massa said, "Shanghai is our 'home ground' in China. We have witnessed the speed of innovation in China, a favorable innovation ecosystem, and high-quality innovative outcomes, and we have firmly chosen Shanghai as an important source of innovation. We will continue to increase our investment, introduce more high-level, high-tech products to Shanghai, benefiting more local patients. At the same time, we will continue to expand the layout of our medical technology products in China, empower the construction of Shanghai's healthcare innovation ecosystem, and help the innovative achievements of local companies benefit the global medical industry."

Medtronic is a global leading medical technology enterprise. The company has established a series of branches in Shanghai, including the Greater China headquarters, China R&D Center, and Medical Innovation Center, with cumulative investments exceeding 7 billion US dollars.